Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

Mise à jour : Il y a 4 ans
Référence : NCT01405599

Femme et Homme

  • | Pays :
  • Slovakia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Evaluation of the effect of hepatic impairment on the pharmacokinetics of ulimorelin after a single intravenous (IV) dose in order to identify potential patients at risks in terms of severity of hepatic dysfunction and to determine whether their dosage should be adjusted.


Critère d'inclusion

  • Digestive System Disorders

Liens